Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011
Ong CT, Thomas SM, Blitzblau RC, Fayanju OM, Park TS, Plichta JK, Rosenberger LH, Hyslop T, Shelley Hwang E, Greenup RA. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011. Annals Of Surgical Oncology 2017, 24: 3559-3566. PMID: 28879416, PMCID: PMC5994237, DOI: 10.1245/s10434-017-6075-0.Peer-Reviewed Original ResearchConceptsAxillary lymph node dissectionBreast cancer patientsAxillary surgeryPatient ageTumor subtypesCancer patientsAmerican CollegeSurgeons Oncology Group Z0011 trialEarly-stage breast cancer patientsNational Cancer Data BaseHuman epidermal growth factor 2Epidermal growth factor 2CN0 breast cancerLimited nodal diseaseUse of SLNBLymph node dissectionTriple-negative diseaseBackgroundThe American CollegeYears of ageACOSOG Z0011ConclusionsAmong womenPatients 70Z0011 trialNodal diseaseNode dissection